| Testcode: | E_PRAVPC |
| Specimens: | 500 µl Serum (s), frozen |
| Preanalytics/Notes: | For the medical clarification of polyuria/polydipsia syndrome. |
| Method: | TRACE assay |
| Dimension: | pmol/l |
| Set-up: | Mon Tue Wed Thu Fri Sat Sun |
| Duration: | 3 days |
| Indication/Significance: |
|
| Interpretation: |
In the differential more… In the differential diagnosis of diabetes insipidus, copeptin proAVP (blood drawn in the morning, fasting, without prior fluid restriction) can be evaluated as follows: Copeptin proAVP > 21.4 pmol/l: nephrogenic diabetes insipidus. Copeptin proAVP < 21.4 pmol/l and sodium < 147 mmol/l: further testing required: Regarding the required further testing, please request the laboratory information on "Copeptin proAVP" from your laboratory. |
| Further tests: | if copeptin proAVP < 21.4 pmol/l, an infusion with 3% NaCl solution should be given until serum sodium has risen > 147 mmol/l. This is followed by another blood draw for determination of stimulated copeptin. The determination of copeptin under 3% NaCl stimulation without prior fluid restriction is clearly superior to the indirect thirst test in the differentiation of patients with primary polydipsia and central diabetes insipidus. A major diagnostic advance is the markedly improved differentiation of patients with primary polydipsia from those with only partial hormone deficiency. (Fenske et al. NEJM 2018; 379: 428-439) |
performance by Bioscientia medical service centers
| both sex | ||
|---|---|---|
|
Copeptin reference range (based on serum osmolality): Osmolality (mosmol/kg) Copeptin proAVP (pmol/l) 270 - 280 0.8 - 11.6 281 - 285 1.0 - 13.7 286 - 290 1.5 - 15.3 291 - 295 2.3 - 24.5 296 - 300 2.4 - 28.2 In the differential diagnosis of diabetes insipidus, copeptin proAVP (blood drawn in the morning, fasting, without prior fluid restriction) can be evaluated as follows: Copeptin proAVP >/= 21.4 pmol/l: nephrogenic diabetes insipidus. Copeptin proAVP < 21.4 pmol/l and sodium < 147 mmol/l: further testing required: Regarding the required further testing, please request the laboratory information on "Copeptin proAVP" from your laboratory. |
||
Die Kosten werden für den i. d. R. genutzten 1,15-fachen GOÄ-Satz dargestellt. Wird die Untersuchung nicht in Ihrem regionalen Labor durchgeführt, erfolgt die Analyse in dem Labor, das im Leistungsverzeichnis genannt ist. In diesem Fall gilt der dort für die Untersuchung angegebene Preis.